ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0.125
0.01
(8.70%)
마감 30 11월 6:00AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.125
매수가
0.12
매도가
0.125
거래량
616,500
0.11 일간 변동폭 0.13
0.06 52주 범위 0.17
market_cap
전일 종가
0.115
개장가
0.12
최근 거래 시간
5000
@
0.125
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
89,053
발행 주식
131,844,000
배당수익률
-
주가수익률
-3.00
주당순이익(EPS)
-0.04
매출
2.82M
순이익
-5.27M

Kane Biotech Inc 정보

섹터
Coml Physical, Biologcl Resh
산업
Coml Physical, Biologcl Resh
웹사이트
본부
Winnipeg, Manitoba, Can
설립됨
-
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX 벤처 거래소 with ticker KNE. The last closing price for Kane Biotech was $0.12. Over the last year, Kane Biotech shares have traded in a share price range of $ 0.06 to $ 0.17.

Kane Biotech currently has 131,844,000 shares in issue. The market capitalisation of Kane Biotech is $15.16 million. Kane Biotech has a price to earnings ratio (PE ratio) of -3.00.

KNE 최신 뉴스

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financial...

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces today that BioStem Technologies Inc...

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will release its third quarter 2024 financial results after market close on...

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of...

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr...

Kane Biotech Announces Agreement to Acquire FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that it has entered into a binding term sheet...

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it is donating 2,000 ounces of revyve™ Antimicrobial...

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution...

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

Kane Biotech Announces Attendance at Upcoming Wound Care Conferences

WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.018.695652173910.1150.130.105306900.11408765CS
4-0.005-3.846153846150.130.130.1605030.11259838CS
12-0.005-3.846153846150.130.1450.1890530.1240693CS
26-0.005-3.846153846150.130.170.1937620.13743271CS
520.0566.66666666670.0750.170.061066120.12715088CS
156-0.04-24.24242424240.1650.170.05665130.11632453CS
260-0.005-3.846153846150.130.260.05676410.13568635CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ENTGEntourage Health Corp
$ 0.015
(200.00%)
2.18M
ACAP.PAtlas One Capital Corporation
$ 0.015
(200.00%)
221.8k
SSESilver Spruce Resources Inc
$ 0.01
(100.00%)
18.01k
XCAP.PExelerate Capital Corp
$ 0.05
(66.67%)
129k
POOLPool Safe Inc
$ 0.04
(60.00%)
158.3k
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
52.11k
OSIXOceansix Future Paths Ltd
$ 0.005
(-50.00%)
2.12M
JHCJinhua Capital Corporation
$ 0.005
(-50.00%)
140k
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
130k
MDK.PMDK Acquisition Inc
$ 0.05
(-50.00%)
5k
EGTEguana Technologies Inc
$ 0.01
(0.00%)
2.55M
ENTGEntourage Health Corp
$ 0.015
(200.00%)
2.18M
OSIXOceansix Future Paths Ltd
$ 0.005
(-50.00%)
2.12M
RIORio2 Limited New
$ 0.63
(-4.55%)
2.11M
GBUGabriel Resources Ltd
$ 0.015
(0.00%)
2.02M

KNE Discussion

게시물 보기
teq0904 teq0904 11 월 전
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
👍️0
teq0904 teq0904 1 년 전
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
👍️0
teq0904 teq0904 1 년 전
cc on Tuesday
👍️0
teq0904 teq0904 1 년 전
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
👍️0
teq0904 teq0904 1 년 전
First closing of the financing is probably next week. Officers and directors are in on it.
👍️0
teq0904 teq0904 1 년 전
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
👍️0
teq0904 teq0904 1 년 전
The next quarterly cc will be late in August.
👍️0
teq0904 teq0904 1 년 전
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
👍️0
teq0904 teq0904 1 년 전
They have FDA approval for coactiv+.
👍️0
J_Dean J_Dean 4 년 전
This is the year. Let’s go! :)
👍️0
Golden Cross Golden Cross 5 년 전
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
👍️0
Golden Cross Golden Cross 5 년 전
KNBIF Website:

https://www.kanebiotech.com/
👍️0
Golden Cross Golden Cross 5 년 전
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
👍️0
Golden Cross Golden Cross 5 년 전
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
👍️0
sfld sfld 5 년 전
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
👍️0
pegcitygreen pegcitygreen 6 년 전
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
👍️0
teq0904 teq0904 6 년 전
CEO got 2M shares in the market now.
👍️0
teq0904 teq0904 6 년 전
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
👍️0
Macaveli Macaveli 6 년 전
Decent news released today. Plus insiders are buying. This is a hidden gem.
👍️0
teq0904 teq0904 6 년 전
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
👍️0

최근 히스토리

Delayed Upgrade Clock